Interferon-β treatment decreases cholesterol plasma levels in multiple sclerosis patients

Neurology

Volumn 62, Issue 5, 2004, Pages 829-830

  Brescia Morra, Vincenzo ^a   Coppola, G ^a   Orefice, G ^a   De Michele, G ^a   Vacca, G ^a   Filla, A ^a   Bonavita, V ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CHOLESTEROL; INTERFERON BETA SERINE; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GENDER; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT;

EID: 1542286032     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000113750.11090.67     Document Type: Article

References (7)

1. Rosenzweig IB, Wiebe DA, Borden EC, Storer B, Shrago ES. Plasma lipoprotein changes in humans induced by beta-interferon. Atherosclerosis 1987;67:261-267.
2. Byskosh PV, Reder AT. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1996;1: 262-269.
3. Andrade RJ, Garcia-Escano MD, Valdivielso P, et al. Effects of interferon-beta on plasma lipid and lipoprotein composition and post-heparin lipase activities in patients with chronic hepatitis C. Aliment Pharmacol Ther 2000;14:929-935.
4. Dixon RM, Borden EC, Keim NL, et al. Decreases in serum high-density-lipoprotein cholesterol and total cholesterol resulting from naturally produced and recombinant DNA-derived leukocyte interferons. Metabolism 1984;33:400-404.
5. Naeem M, Bacon BR, Mistry B, Britton RS, Di Bisceglie AM. Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C. Am J Gastroenterol 2001;96:2468-2472.
6. Sena A, Pedrosa R, Ferret-Sena V, et al. Interferon beta1a therapy changes lipoprotein metabolism in patients with multiple sclerosis. Clin Chem Lab Med 2000;38:209-213.
7. Giubilei F, Antonini G, Di Legge S, et al. Blood cholesterol and MRI activity in first clinical episode suggestive of multiple sclerosis. Acta Neurol Scand 2002;106:109-112.